A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT05416749 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

216

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor development strategy adjustment

Conditions

Solid Tumors

Interventions

DRUG: 8MW2311

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.